• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Gentherm Announces Dr. Ken Washington as New Independent Director

    10/2/23 8:00:00 AM ET
    $AMZN
    $F
    $MCK
    $MDT
    Catalog/Specialty Distribution
    Consumer Discretionary
    Auto Manufacturing
    Industrials
    Get the next $AMZN alert in real time by email

    NORTHVILLE, Mich., Oct. 02, 2023 (GLOBE NEWSWIRE) -- Gentherm (NASDAQ:THRM), the global market leader of innovative thermal management and pneumatic comfort technologies for the automotive industry and a leader in medical patient temperature management systems, today announced that Dr. Ken Washington has been appointed to the Company's Board of Directors, effective October 2, 2023.

    Dr. Washington is the Senior Vice President, Chief Technology and Innovation Officer of Medtronic plc (NYSE:MDT), a global healthcare technology company that provides device-based medical therapies and services. He was appointed to this position in June 2023, and he leads innovation and the expansion of technology platforms across Medtronic's portfolio. Prior to joining Medtronic, Dr. Washington served as the Vice President of Software Engineering, Consumer Robotics for Amazon Lab126, a premier innovation hub and subsidiary of Amazon.com, Inc. (NASDAQ:AMZN). At Amazon Lab 126, Dr. Washington was responsible for all aspects of the profitability of Amazon's consumer robotics business unit. Before Amazon Lab 126, he held varying positions at Ford Motor Company (NYSE:F), including serving as Chief Technology Officer. At Ford, he led the worldwide research organization, oversaw the development and implementation of Ford's technology strategy and plans, oversaw the autonomous vehicle program, and played a key role in Ford's expansion into emerging mobility opportunities. Dr. Washington worked at Lockheed Martin Corporation as Vice President of the Advanced Technology Center and its first Chief Privacy Officer. Dr. Washington also served for approximately 21 years in various roles at Sandia National Laboratories, including as Chief Information Officer.

    Dr. Washington previously served as a member of the Board of Directors of McKesson Corporation (NYSE:MCK) from July 2019 to October 2021, including as a member of the Compliance and Finance Committees, as well as numerous private company boards and advisory boards of academic institutions.

    "We are pleased to welcome Ken to Gentherm's Board of Directors," said Ronald Hundzinski, Chair of the Board of Gentherm. "Ken brings years of experience in technology, research, and strategy across global automotive and medical organizations that will be a valuable asset to Gentherm's Board."

    "Ken's strong track record of leading technology development and execution makes him an ideal Board member to help drive innovation and strategy to strengthen shareholder value," said Phil Eyler, President and CEO of Gentherm. "I look forward to his insight and counsel and am excited for him to join as a new member of our Board of Directors."

    Dr. Washington earned his bachelor's, master's, and doctorate degrees in nuclear engineering from Texas A&M University.

    Investor Contact

    Yijing Brentano

    [email protected]

    248.308.1702

    Media Contact

    Melissa Fischer

    [email protected]

    248.289.9702

    About Gentherm

    Gentherm (NASDAQ:THRM) is the global market leader in innovative thermal management and pneumatic comfort technologies for the automotive industry and a leader in medical patient temperature management systems. Automotive products include variable temperature Climate Control Seats, heated automotive interior systems (including heated seats, steering wheels, armrests, and other components), battery performance solutions, cable systems, lumbar and massage comfort solutions, valve system technologies, and other electronic devices. Medical products include patient temperature management systems. The Company is also developing a number of new technologies and products that will help enable improvements to existing products and to create new product applications for existing and new markets. Gentherm has more than 14,000 employees in facilities in the United States, Germany, China, Czech Republic, Hungary, Japan, Malta, Mexico, North Macedonia, South Korea, United Kingdom, Ukraine, and Vietnam. For more information, go to www.gentherm.com.



    Primary Logo

    Get the next $AMZN alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AMZN
    $F
    $MCK
    $MDT

    CompanyDatePrice TargetRatingAnalyst
    Amazon.com Inc.
    $AMZN
    8/1/2025$260.00 → $280.00Overweight
    Cantor Fitzgerald
    Amazon.com Inc.
    $AMZN
    8/1/2025$225.00 → $260.00Positive
    Susquehanna
    Amazon.com Inc.
    $AMZN
    8/1/2025$230.00 → $265.00Buy
    DA Davidson
    Amazon.com Inc.
    $AMZN
    8/1/2025$250.00 → $245.00Outperform
    Oppenheimer
    Amazon.com Inc.
    $AMZN
    8/1/2025$262.00 → $260.00Buy
    Stifel
    Amazon.com Inc.
    $AMZN
    8/1/2025$250.00 → $255.00Overweight
    Piper Sandler
    Amazon.com Inc.
    $AMZN
    8/1/2025$255.00 → $265.00Overweight
    Analyst
    Amazon.com Inc.
    $AMZN
    8/1/2025$265.00 → $272.00Buy
    BofA Securities
    More analyst ratings

    $AMZN
    $F
    $MCK
    $MDT
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Inovalon Launches AI Solution in Partnership With AWS To Help Health Plans Meet New RADV Audit Requirements

    Advanced AI/ML Solution Improves Risk Score Accuracy and RADV Audit Readiness for Health Plans Inovalon, a leading provider of solutions empowering data-driven healthcare, today announced an expansion of its collaboration with Amazon Web Services (NASDAQ:AMZN), further enhancing its Converged Record Review™ solution. The solution accommodates the latest regulatory requirements after the Centers for Medicare & Medicaid Services (CMS) announcement requiring annual Risk Adjustment Data Validation (RADV) audits for all Medicare Advantage (MA) contracts, beginning in 2026. Health plans operate under increased scrutiny of their clinical support for submitted diagnoses, and face operational bu

    8/19/25 8:00:00 AM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    Medtronic announces Board appointments and shareholder value creation initiatives to advance strategic priorities

    Experienced executives John Groetelaars and Bill Jellison appointed to the Board of Directors Board forms new Growth and Operating committees to sharpen focus on the company's ongoing strategic portfolio management, operational execution and capital allocation Plan to host Investor Day in 2026 Initiatives follow constructive engagement with Elliott Management GALWAY, Ireland, Aug. 19, 2025 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced the Medtronic Board of Directors has appointed John Groetelaars and Bill Jellison as independent directors, effective immediately. Consistent with the company's commitment to shareholder value creation, and

    8/19/25 6:46:00 AM ET
    $MDT
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Medtronic reports first quarter fiscal 2026 financial results

    11th quarter in a row of mid-single digit organic revenue growth;Poised to accelerate growth GALWAY, Ireland, Aug. 19, 2025 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced financial results for its first quarter (Q1) of fiscal year 2026 (FY26), which ended July 25, 2025. Key Highlights Revenue of $8.6 billion, adjusted revenue of $8.5 billion, increased 8.4% as reported and 4.8% organicGAAP diluted EPS of $0.81 increased 1%; non-GAAP diluted EPS of $1.26 increased 2%Company raises FY26 EPS guidance; reiterates FY26 organic revenue growth guidanceCardiac Ablation Solutions revenue increased nearly 50%, incl

    8/19/25 6:45:00 AM ET
    $MDT
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $AMZN
    $F
    $MCK
    $MDT
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Washington Kenneth E bought $47,702 worth of shares (1,700 units at $28.06), increasing direct ownership by 18% to 10,965 units (SEC Form 4)

    4 - Gentherm Inc (0000903129) (Issuer)

    5/13/25 4:10:38 PM ET
    $THRM
    Auto Parts:O.E.M.
    Consumer Discretionary

    Director Hundzinski Ronald T bought $133,350 worth of shares (5,000 units at $26.67), increasing direct ownership by 38% to 18,006 units (SEC Form 4)

    4 - Gentherm Inc (0000903129) (Issuer)

    5/12/25 4:06:43 PM ET
    $THRM
    Auto Parts:O.E.M.
    Consumer Discretionary

    SVP, General Manager, Europe Stocker Thomas bought $8,011 worth of shares (321 units at $24.96), increasing direct ownership by 2% to 20,638 units (SEC Form 4)

    4 - Gentherm Inc (0000903129) (Issuer)

    4/29/25 8:46:29 PM ET
    $THRM
    Auto Parts:O.E.M.
    Consumer Discretionary

    $AMZN
    $F
    $MCK
    $MDT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Executive Chair Bezos Jeffrey P gifted 100,020 shares, decreasing direct ownership by 0.01% to 883,679,881 units (SEC Form 4)

    4 - AMAZON COM INC (0001018724) (Issuer)

    8/18/25 4:31:30 PM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    CEO Worldwide Amazon Stores Herrington Douglas J gifted 8,970 shares, decreasing direct ownership by 2% to 503,080 units (SEC Form 4)

    4 - AMAZON COM INC (0001018724) (Issuer)

    8/12/25 4:24:43 PM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    SVP, Controller & CAO Rutledge Napoleon B Jr sold $218,347 worth of shares (329 units at $663.67), decreasing direct ownership by 33% to 657 units (SEC Form 4)

    4 - MCKESSON CORP (0000927653) (Issuer)

    8/11/25 4:52:21 PM ET
    $MCK
    Other Pharmaceuticals
    Health Care

    $AMZN
    $F
    $MCK
    $MDT
    SEC Filings

    View All

    Medtronic plc. filed SEC Form 8-K: Results of Operations and Financial Condition, Leadership Update, Financial Statements and Exhibits

    8-K - Medtronic plc (0001613103) (Filer)

    8/19/25 6:49:43 AM ET
    $MDT
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    SEC Form 10-Q filed by McKesson Corporation

    10-Q - MCKESSON CORP (0000927653) (Filer)

    8/6/25 5:30:47 PM ET
    $MCK
    Other Pharmaceuticals
    Health Care

    McKesson Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - MCKESSON CORP (0000927653) (Filer)

    8/6/25 4:06:31 PM ET
    $MCK
    Other Pharmaceuticals
    Health Care

    $AMZN
    $F
    $MCK
    $MDT
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    March 11, 2025 - FDA Roundup: March 11, 2025

    For Immediate Release: March 11, 2025 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:Today, the FDA published a General Correspondence Letter issued to Mid-Link Technology Testing Co., Ltd. The FDA is vigilant in ensuring data submitted to the FDA can be relied upon to assess the effectiveness, safety, or risk of a device. The FDA has noted an incr

    3/13/25 3:14:00 PM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    November 14, 2023 - FDA Roundup: November 14, 2023

    For Immediate Release: November 14, 2023 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  On Monday, the FDA updated the advisory for the Investigation of Elevated Lead Levels in Cinnamon Applesauce Pouches to include an expanded recall from WanaBana LLC to include Weis and Schnucks-brand cinnamon applesauce pouches. As of November 13, 2023, there

    11/14/23 3:26:18 PM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    $AMZN
    $F
    $MCK
    $MDT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Cantor Fitzgerald reiterated coverage on Amazon with a new price target

    Cantor Fitzgerald reiterated coverage of Amazon with a rating of Overweight and set a new price target of $280.00 from $260.00 previously

    8/1/25 11:06:40 AM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    Susquehanna reiterated coverage on Amazon with a new price target

    Susquehanna reiterated coverage of Amazon with a rating of Positive and set a new price target of $260.00 from $225.00 previously

    8/1/25 11:06:40 AM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    DA Davidson reiterated coverage on Amazon with a new price target

    DA Davidson reiterated coverage of Amazon with a rating of Buy and set a new price target of $265.00 from $230.00 previously

    8/1/25 11:06:13 AM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    $AMZN
    $F
    $MCK
    $MDT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Amazon.com Inc.

    SC 13G/A - AMAZON COM INC (0001018724) (Subject)

    11/8/24 4:33:15 PM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by Amazon.com Inc.

    SC 13G/A - AMAZON COM INC (0001018724) (Filed by)

    11/7/24 5:23:12 PM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    SEC Form SC 13G/A filed by Medtronic plc. (Amendment)

    SC 13G/A - Medtronic plc (0001613103) (Subject)

    2/13/24 5:09:43 PM ET
    $MDT
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $AMZN
    $F
    $MCK
    $MDT
    Financials

    Live finance-specific insights

    View All

    Medtronic reports first quarter fiscal 2026 financial results

    11th quarter in a row of mid-single digit organic revenue growth;Poised to accelerate growth GALWAY, Ireland, Aug. 19, 2025 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced financial results for its first quarter (Q1) of fiscal year 2026 (FY26), which ended July 25, 2025. Key Highlights Revenue of $8.6 billion, adjusted revenue of $8.5 billion, increased 8.4% as reported and 4.8% organicGAAP diluted EPS of $0.81 increased 1%; non-GAAP diluted EPS of $1.26 increased 2%Company raises FY26 EPS guidance; reiterates FY26 organic revenue growth guidanceCardiac Ablation Solutions revenue increased nearly 50%, incl

    8/19/25 6:45:00 AM ET
    $MDT
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Medtronic announces cash dividend for second quarter of fiscal year 2026

    GALWAY, Ireland, Aug. 14, 2025 /PRNewswire/ -- The board of directors of Medtronic plc (NYSE:MDT) on Thursday, August 14, 2025, approved the company's cash dividend for the second quarter of fiscal year 2026 of $0.71 per ordinary share. This quarterly declaration is consistent with the dividend increase announcement made by the company in May 2025. Medtronic is a constituent of the S&P 500 Dividend Aristocrats index, having increased its annual dividend payment for the past 48 consecutive years. The dividend is payable on October 17, 2025, to shareholders of record at the close of business on September 26, 2025. About Medtronic Bold thinking. Bolder actions. We are Medtronic. Medtronic plc,

    8/14/25 4:15:00 PM ET
    $MDT
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    McKesson Corporation Reports Fiscal 2026 First Quarter Results and Raises Full Year Adjusted EPS Guidance

    McKesson Corporation (NYSE:MCK) has released its fiscal 2026 first quarter financial results. Results can be accessed on McKesson's Investor Relations website at investor.mckesson.com/financials/quarterly-results. As previously announced, the company will host a live webcast of the earnings conference call for investors today, Wednesday, August 6 at 4:30 PM ET to review its financial results. The audio webcast of the conference call will be available live and archived on McKesson's Investor Relations website, along with the company's earnings press release, financial tables, and slide presentation. Additional information about upcoming events for the investor community can be found at inv

    8/6/25 4:10:00 PM ET
    $MCK
    Other Pharmaceuticals
    Health Care

    $AMZN
    $F
    $MCK
    $MDT
    Leadership Updates

    Live Leadership Updates

    View All

    ChargeScape and PSEG Long Island Partner to Enroll BMW and Ford Electric Vehicles in First-Ever Grid Reliability Program Participation

    HICKSVILLE, N.Y., July 22, 2025 (GLOBE NEWSWIRE) -- ChargeScape, a joint venture between BMW, Honda, Ford, and Nissan, today announced a partnership with PSEG Long Island to enroll electric vehicles (EVs) in the utility's Peak Load Reduction program, a first in the nine-year history of the utility's peak load reduction programs. Designed to alleviate strain on the power grid during summer months, the initiative will leverage ChargeScape's AI-powered technology platform and aims to intelligently integrate more than 4,000 BMW EV drivers and 2,200 Ford EV drivers into the power grid. Participating customers will receive financial incentives for helping to support grid stability and community

    7/22/25 7:00:00 AM ET
    $F
    Auto Manufacturing
    Industrials

    Medtronic announces appointment of MiniMed chief financial officer ahead of intended separation into standalone company

    GALWAY, Ireland, July 8, 2025 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced the appointment of Chad Spooner as chief financial officer (CFO) of MiniMed, in advance of its intended separation into a standalone, public company. Effective July 14, 2025, Chad will be responsible for overseeing the Finance function for Medtronic Diabetes and supporting initiatives aimed at accelerating profitable growth and delivering shareholder value as it prepares to become fully independent.  Chad brings over 25 years of financial leadership experience across healthcare, consumer, and industrial sectors. Most recently, he served as CFO at BIC (BB:PA), a pu

    7/8/25 8:45:00 AM ET
    $MDT
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Medtronic Board appoints Dr. Joon Lee as a new director

    GALWAY, Ireland, June 23, 2025 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that its Board of Directors appointed Dr. Joon Lee, CEO at Emory Healthcare, Inc., to the Board as an independent director, effective June 18, 2025. Dr. Lee will serve on the Science and Technology Committee and Compensation and Talent Committee of the Board. "We are thrilled to welcome Dr. Lee, a highly respected interventional cardiologist and healthcare executive, to Medtronic's Board of Directors," said Geoff Martha, chairman and chief executive officer. "Dr. Lee brings deep expertise as a clinical researcher, academic leader, and physician executive with dec

    6/23/25 4:15:00 PM ET
    $MDT
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care